Evidence map›Paper›PMID 36678902›Full record

ArticlePharmaceutics2023

Nanoparticles of

Alexander Yu Rybkin, Svetlana V Kurmaz, Elizaveta A Urakova, Natalia V Filatova, Lev R Sizov, Alexey V Kozlov, Mikhail O Koifman, Nikolai S Goryachev

Abstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Macromolecular Design and Engineering of New AmphiphilicInternational journal of molecular sciences · 2023
    Article
  8. Emerging Applications ofBioengineering (Basel, Switzerland) · 2023
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexander Yu RybkinFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Pr. Akademika Semenova 1, 142432 Chernogolovka, Russia.ORCID 0000-0002-3764-7444
Svetlana V KurmazFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Pr. Akademika Semenova 1, 142432 Chernogolovka, Russia.ORCID 0000-0001-8269-8630
Elizaveta A UrakovaFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Pr. Akademika Semenova 1, 142432 Chernogolovka, Russia.
Natalia V FilatovaFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Pr. Akademika Semenova 1, 142432 Chernogolovka, Russia.
Lev R SizovFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Pr. Akademika Semenova 1, 142432 Chernogolovka, Russia.
Alexey V KozlovFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Pr. Akademika Semenova 1, 142432 Chernogolovka, Russia.ORCID 0000-0003-0133-0776
Mikhail O KoifmanDepartment of Chemistry and Technology of Macromolecular Compounds, Ivanovo State University of Chemistry and Technology, Sheremetevskiy Av. 7, 153000 Ivanovo, Russia.
Nikolai S GoryachevFederal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Pr. Akademika Semenova 1, 142432 Chernogolovka, Russia.

Funding

Ministry of Education and Science of the Russian Federation АААА-А19-119071890015-6Ministry of Education and Science of the Russian Federation АААА-А19-119112590105-7
6 · The paper itself

Abstract

A series of nanoparticles (NPs) with a hydrodynamic radius from 20 to 100 nm in PBS was developed over the solubilization of hydrophobic dye methyl pheophorbide

Indexed as

amphiphilic copolymerschlorin e6(di)methacrylatesnanoparticlesN-vinylpyrrolidonePDTpheophorbidephotodynamic actionphotosensitizer

Identifiers

PMID36678902
PMCPMC9863766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.